STAAR Surgical ICL Sales Up 67%; Company Raises Outlook for 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
STAAR Surgical (STAA) Tops Q2 EPS by 10c, Revenues Beat; Boosts Outlook
August 1, 2018 4:06 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q2 EPS of $0.09, $0.10 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $26.74 million.
Second Quarter 2018 Overview
Net Sales of $33.9 Million Up 55% from the Prior Year QuarterICL Sales Up 67% and Units Up 66% from the Prior Year QuarterOther Sales Up 18% from the Prior Year QuarterGross Margin at 74.4% of Sales from 70.5% of Sales in the Prior Year... More